WallStreetZenWallStreetZen

NASDAQ: OBIO
Orchestra Biomed Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

OBIO past revenue growth

How has OBIO's revenue growth performed historically?
Company
-52.15%
Industry
73.78%
Market
17.41%
OBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

OBIO earnings and revenue history

Current Revenue
$2.1M
Current Earnings
-$55.6M
Current Profit Margin
-2,673.3%

OBIO Return on Equity

Current Company
-89.3%
Current Industry
22.8%
Current Market
33.8%
OBIO's Return on Equity (-89.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OBIO announces earnings.

OBIO Return on Assets

Current Company
-60.6%
Current Industry
3.5%
OBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OBIO Return on Capital Employed

Current Company
-92.87%
Current Industry
21.4%
OBIO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OBIO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OBIO$2.08M-$52.92M-$55.58M+107.04%N/A
TELO$0.00N/A-$18.74MN/AN/A
AMLX$298.76M-$161.24M-$165.87M+3,137.73%N/A
GLSI$0.00-$10.21M-$10.22MN/AN/A
VXRT$13.93M-$66.59M-$75.66M+13.06%N/A
View Top Biotech Stocks

Orchestra Biomed Holdings Earnings & Revenue FAQ

What were OBIO's earnings last quarter?

Orchestra Biomed Holdings (NASDAQ: OBIO) reported Q2 2024 earnings per share (EPS) of -$0.45, up 28.57% year over year. Total Orchestra Biomed Holdings earnings for the quarter were -$15.98 million. In the same quarter last year, Orchestra Biomed Holdings's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Orchestra Biomed Holdings stock.

What was OBIO's earnings growth in the past year?

As of Q3 2024, Orchestra Biomed Holdings's earnings has grown year over year. Orchestra Biomed Holdings's earnings in the past year totalled -$55.58 million.

What was OBIO's revenue last quarter?

Orchestra Biomed Holdings (NASDAQ: OBIO) reported Q2 2024 revenue of $778.00 thousand up 14.97% year over year. In the same quarter last year, Orchestra Biomed Holdings's revenue was $915.00 thousand.

What was OBIO's revenue growth in the past year?

As of Q3 2024, Orchestra Biomed Holdings's revenue has grown -52.15% year over year. This is 125.93 percentage points lower than the US Biotechnology industry revenue growth rate of 73.78%. Orchestra Biomed Holdings's revenue in the past year totalled $2.08 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.